Adverse effects of dopamine potentiation by long-term treatment with selegiline
A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2004
|
| Sorozat: | MOVEMENT DISORDERS
19 No. 1 |
| doi: | 10.1002/mds.10641 |
| mtmt: | 1032213 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/10113 |
| Tartalmi kivonat: | A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal. Monoamine oxidase-B platelet activity was low in this patient. (C) 2003 Movement Disorder Society. |
|---|---|
| Terjedelem/Fizikai jellemzők: | 107-109 |
| ISSN: | 0885-3185 |